Figure 2From: Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance studyRelationship between carbapenem-resistant Kp isolates per year and overall and serious ADR reports per year concerning agents with proven efficacy against CRE (colistin, meropenem, tigecycline, gentamicin and ceftazidime-avibactam) from 2009 to 2017 (after the KPC outbreak) in Italy (white and grey squares identifying respectively overall and serious ADRs) and UK (black and grey triangles identifying respectively overall and serious ADRs). Significant positive correlations were found for both countriesBack to article page